Bio Pharma Dive
JANUARY 21, 2021
Katherine High and Jude Samulski, two well-known gene therapy researchers, were longtime collaborators and competitors. Now they're colleagues at one of the world's largest drugmakers.
World of DTC Marketing
JANUARY 21, 2021
SUMMARY: Among US adults who looked for health information and used the internet for their most recent search, the percentage who reported accessing health information without frustration was stable during the study period (from 37.2% in 2008 to 38.5% in 2017). The percentage of online health information seekers reporting easily accessing health information did not meet the HP2020 objective.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
BioSpace
JANUARY 21, 2021
Despite the rising number of COVID-19 cases reported across the globe, rates of influenza have virtually flatlined across the Northern Hemisphere, leading many doctors and researchers to wonder how this could be replicated in non-pandemic times.
pharmaphorum
JANUARY 21, 2021
A partnership between University of Oxford, the Earlham Institute, and the global pharmaceutical companies Biogen Inc and Boehringer Ingelheim is announced today to investigate a new drug target for the treatment of schizophrenia. This is the first project to be funded by the international Psychiatry Consortium, a £4 million collaboration between seven global pharmaceutical companies, and two leading research charities, convened and managed by the Medicines Discovery Catapult, that supports high
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
BioPharma Reporter
JANUARY 21, 2021
The team behind the Oxford-AstraZeneca COVID-19 vaccine says it is carefully assessing the impact of new variants from the UK, South Africa and Brazil on vaccine immunity.
BioSpace
JANUARY 21, 2021
Ten pharmaceutical companies have joined forces again to launch Accumulus Synergy Inc., a non-profit effort to pool data in the cloud and interact with regulators, in the hopes of speeding the drug approval process.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
BioSpace
JANUARY 21, 2021
With the Pfizer-BioNTech and Moderna COVID-19 vaccines currently authorized in the U.S. and being distributed and dosed, some of the attention is shifting to Johnson & Johnson’s efforts for its one-shot vaccine.
BioPharma Reporter
JANUARY 21, 2021
VBI Vaccines is due to start a Phase 1/2 study of a coronavirus vaccine candidate in Q1 2021, after a preclinical hamster challenge study demonstrated ârobust immunogenicity and efficacyâ.
pharmaphorum
JANUARY 21, 2021
With clinical holds lifting there has been more investment and clinical progress in the gene therapy for muscular disorders space than ever before, yet the consequences of toxicity are not a distant memory. Despite the successes, there are still withstanding challenges for gene therapy developers targeting the muscle when it comes to optimizing delivery and navigating toxicity to develop truly safe and transformative therapeutics for muscular disorders patients.
Druggist
JANUARY 21, 2021
The main focus of today’s post is to review the most popular prescription painkillers in the UK. I previously reviewed the popularity of different drugs in the UK, which may interest you: Top 15 most prescribed drugs in the UK & most popular antidepressants in the UK. Most popular prescription painkillers (UK) will be ranked according to the volume of prescriptions issued in the last 12 months by GPs in the UK.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Pharma Times
JANUARY 21, 2021
Antibodies in blood of vaccinated individuals neutralised in vivo version of variant
BioSpace
JANUARY 21, 2021
Americans are still hesitant to be vaccinated against COVID-19, according to just-released research from Invisibly.
pharmaphorum
JANUARY 21, 2021
While restrictions on travel could prevent coronavirus transmission in the short term, digital passports showing COVID-negative and vaccination status may help reopen airports and other badly hit areas of the economy, reports Richard Staines. UK health secretary Matt Hancock has ruffled feathers this week by urging Britons to holiday in the UK this year to prevent transmission of the coronavirus.
BioSpace
JANUARY 21, 2021
One year and more than 410,000 deaths later, the United States is still firmly in the grips of the COVID-19 pandemic.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
Outsourcing Pharma
JANUARY 21, 2021
The trials, funded by the American Heart Association, will harness the companyâs Verisense wearable sensor platform to examine brain-heart health links.
BioSpace
JANUARY 21, 2021
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
NY Times
JANUARY 21, 2021
A monoclonal antibody protected residents and staff members in facilities where the virus had appeared.
Pharma Times
JANUARY 21, 2021
Over 400,000 people in the UK live with RA
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
NY Times
JANUARY 21, 2021
A monoclonal antibody protected residents and staff members in facilities where the virus had appeared.
pharmaphorum
JANUARY 21, 2021
Bayer and Merck & Co’s heart failure drug vericiguat has been approved by the FDA under the brand name Verquvo, in an increasingly competitive market. Verquvo has been approved to reduce risk of cardiovascular death and heart failure hospitalisation in adults with symptomatic chronic heart failure and ejection fraction less than 45%. The drug can be used after hospitalisation for heart failure or in patients in need of intravenous diuretics.
NY Times
JANUARY 21, 2021
A combination of two injectable drugs will provide an alternative to daily pills for people with H.I.V.
pharmaphorum
JANUARY 21, 2021
86% of respondents to a recent Veeva survey of pharma and biotech professionals said they are creating a greater volume of content now, compared to six months ago. Yet while many pharma companies are creating more content than ever before, they also face increased pressure to quickly deliver highly personalised – and compliant – content to HCPs.
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
BioSpace
JANUARY 21, 2021
The drug, a combination of cabotegravir and rilpivirine, is a complete therapy for HIV-1 infection in adults who are virologically suppressed.
Scienmag
JANUARY 21, 2021
Researchers urge UK to keep EU ban on pesticide which has detrimental effect on pollinators Just like us, many insects need a decent night’s sleep to function properly, but this might not be possible if they have been exposed to neonicotinoid insecticides, the most common form of insecticide used worldwide, suggests research by academics at […].
BioSpace
JANUARY 21, 2021
GSK has discontinued a Phase II clinical trial evaluating an anti-LAG3 cell depleting monoclonal antibody aimed at treating ulcerative colitis licensed from Immutep Limited following an interim assessment of an Independent Data Monitoring Committee.
Scienmag
JANUARY 21, 2021
Trace fossil reveals more about this ancient creature’s behavior Credit: Masakazu Nara Simon Fraser University researchers have found evidence that large ambush-predatory worms–some as long as two metres–roamed the ocean floor near Taiwan over 20 million years ago. The finding, published today in the journal Scientific Reports, is the result of reconstructing an unusual trace […].
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
XTalks
JANUARY 21, 2021
Oikos has started the new year by introducing new protein-filled products to their dairy line. Their products provide a good source of protein, calcium and come in two snackable forms that boast up to 25 grams of protein. Their new snackable products come in two forms: a snackable cup and a drinkable bottle. The snacks provide about 40 percent of the recommended daily value for protein and 15 percent of the recommended daily value for calcium.
Scienmag
JANUARY 21, 2021
Study of heart-rate sensor earns praise for UMass Lowell team LOWELL, Mass. – UMass Lowell students testing a new device that could transform the way heart-rate data is collected have won praise for their work from the American College of Sports Medicine. A portable sensor that collects heart-rate data shows promise for its accuracy and […].
Pharma Times
JANUARY 21, 2021
Drug approved to reduce the risk of cardiovascular death/heart failure hospitalisation
BioSpace
JANUARY 21, 2021
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
Advertisement
The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
Expert insights. Personalized for you.
341 
Let's personalize your content